Company intelligence / Profile preview

LactaLogics

Port St. Lucie, Florida, United Stateslactalogics.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Currently building a state-of-the-art human milk processing facility, with 50% completion as of December 2024. The facility is on track for completion in late 2025[4].

Therapeutic areas: Metabolic Disorders
Modalities: Human milk-based nutrition products
Industry: Food & Nutrition

Drug pipeline

2 assets

100% Donor Human Milk

Pre-clinical

Indications: Infant nutrition, Premature infant nutrition

1 more asset in the full pipeline.

Request access →

Partnerships

Scholle IPN (packaging technology partner)[5]

Beyond the preview

Go deeper on LactaLogics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LactaLogics.

Explore the full profile